Article Details

Analysts estimate Akebia Therapeutics, Inc. (AKBA) To Grow by 11.24%: Here is Why

Retrieved on: 2019-09-13 01:26:15

Tags for this article:

Click the tags to see associated articles and topics

Analysts estimate Akebia Therapeutics, Inc. (AKBA) To Grow by 11.24%: Here is Why. View article details on HISWAI:

Excerpt

<div>Now turning to institutional ownership of Akebia Therapeutics, Inc. (AKBA), The <b>Baupost Group</b> LLC is the top holder with 24.47 million shares.</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up